Fairvalue-Calculator Fairvalue-Calculator
EN DE

Universe Pharmaceuticals INC, through its subsidiaries, (UPC) Fair Value & Analysis

Healthcare · US · Market cap $2.0M

Price$2.95
Fair Value$3.26
Upside+10.4%
Quality95/100
Evidence: Low Range $2.44 – $4.07

Fair value as of: Jun 25, 2026

Analysis

Universe Pharmaceuticals INC, through its subsidiaries, (UPC) currently trades at $2.95, while our model-based Fair Value estimate is $3.26 — implying the stock looks roughly 10.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. …

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Universe Pharmaceuticals INC, through its subsidiaries, (UPC) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $3.26 versus a price of $2.95 — about +10% (undervalued). Model-based estimate, not financial advice.
What is the fair value of UPC?
Our 21-model fair value for Universe Pharmaceuticals INC, through its subsidiaries, is $3.26 (as of Jun 25, 2026), built from audited fundamentals. The current price is $2.95.
What is the quality score of UPC?
Universe Pharmaceuticals INC, through its subsidiaries, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.